Amplifon S.p.A. (AMFPF)
OTCMKTS · Delayed Price · Currency is USD
18.00
0.00 (0.00%)
Oct 23, 2025, 8:00 PM EDT
Amplifon Market Cap
Amplifon has a market cap or net worth of $4.06 billion as of October 24, 2025. Its market cap has decreased by -40.07% in one year.
Market Cap
4.06B
Enterprise Value
5.91B
Revenue
2.83B
Ranking
n/a
PE Ratio
27.47
Stock Price
$18.00
Market Cap Chart
Since June 27, 2001, Amplifon's market cap has increased from 307.81M to 4.06B, an increase of 1,217.54%. That is a compound annual growth rate of 11.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 24, 2025 | 4.06B | -30.25% |
| Dec 30, 2024 | 5.81B | -25.58% |
| Dec 29, 2023 | 7.81B | 16.98% |
| Dec 30, 2022 | 6.68B | -44.71% |
| Dec 30, 2021 | 12.08B | 28.61% |
| Dec 30, 2020 | 9.39B | 46.59% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 806.69M |
| Elite Pharmaceuticals | 670.91M |
| Glass House Brands | 619.92M |
| Northwest Biotherapeutics | 371.21M |
| Silence Therapeutics | 344.81M |
| Nika Pharmaceuticals | 335.28M |
| CytoDyn | 327.16M |
| American Oncology Network | 291.52M |